Charles Schwab Investment Management Inc Aytu Biopharma, Inc Transaction History

Charles Schwab Investment Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.73 - $7.56 $259,695 - $415,074	-54,904 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.23 - $9.88 $273,478 - $433,702	43,897 Added 398.81%	54,904 $418,000
Q4 2020 Feb 16, 2021	BUY	$5.98 - $13.5 $65,821 - $148,594	11,007 New	11,007 $66,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $93.6M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.